CN102302631A - Medicine-partition moxibustion navel Chinese medicinal composition for treating tubal obstruction infertility - Google Patents

Medicine-partition moxibustion navel Chinese medicinal composition for treating tubal obstruction infertility Download PDF

Info

Publication number
CN102302631A
CN102302631A CN 201110270890 CN201110270890A CN102302631A CN 102302631 A CN102302631 A CN 102302631A CN 201110270890 CN201110270890 CN 201110270890 CN 201110270890 A CN201110270890 A CN 201110270890A CN 102302631 A CN102302631 A CN 102302631A
Authority
CN
China
Prior art keywords
grams
medicine
chinese medicinal
medicinal composition
infertility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 201110270890
Other languages
Chinese (zh)
Other versions
CN102302631B (en
Inventor
高树中
马玉侠
杜冬青
王秀英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong University of Traditional Chinese Medicine
Original Assignee
Shandong University of Traditional Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong University of Traditional Chinese Medicine filed Critical Shandong University of Traditional Chinese Medicine
Priority to CN 201110270890 priority Critical patent/CN102302631B/en
Publication of CN102302631A publication Critical patent/CN102302631A/en
Application granted granted Critical
Publication of CN102302631B publication Critical patent/CN102302631B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a medicine-partition moxibustion navel Chinese medicinal composition for treating tubal obstruction infertility. The Chinese medicinal composition comprises the following raw materials by weight: 10 to 15 grams of garden balsam stem, 10 to 20 grams of dragon's blood, 10 to 15 grams of camphor, 10 to 15 grams of angelica dahurica, 10 to 20 grams of myrrh, 15 to 25 grams of frankincense, 10 to 15 grams of medcinal evodia fruit, 10 to 15 grams of raw pinellia tuber, 10 to 20 grams of gleditsia thorn and 4 to 8 grams of borneol. The Chinese medicinal composition is applied externally, does not have toxic or side effect, is used for treatment in a medicine-partition moxibustion navel method and has the advantages of simplicity, convenience, low cost and quick response, and the injury of oral medicaments to stomachs and intestines, livers and kidneys is avoided; and the Chinese medicinal composition has an effect caused by stimulating acupoint by moxa-moxibustion and also has a direct effect generated after the medicaments are absorbed, so the Chinese medicinal composition has quick response and a definite curative effect for treating tubal obstruction infertility by external treatment for internal diseases under the action of the two effects. In addition, the medicine-partition moxibustion navel Chinese medicinal composition is low in cost and readily available and therefore is convenient to popularize and apply.

Description

A kind of fumigating medicine to cauterize navel Chinese medicine composition of treating oviduct obstructive sterility
Technical field
The present invention relates to a kind of Chinese medicine composition of treating infertility, be specifically related to a kind of external Chinese medicine of treating oviduct obstructive sterility.
Background technology
Infertility (Infertility) is a kind of special healthy reproduction defective, also is one of the theme in present reproductive medicine field.Infertile factor maybe be on the wife's side, the bridegroom's or husband's side or men and women, because wife's side factor causer is an infertility, accounts for 40-50%.The reason of infertility has multiple, comprises ovulation failure, fallopian tube factor, uterus factor, cervix uteri factor, vagina factor etc.At present; In many factors, be main still with the fallopian tube factor; And along with increasing of environmental pollution, sexually transmitted disease (STD), intrauterine infection, endometriosis; Diseases of fallopian tubes causes the incidence rate of infertility on the rise, has important clinical significance and practical value so actively inquire into effective Therapeutic Method of oviduct obstructive sterility.
The western medical treatment method mainly contains the unobstructed art of fallopian tube, selective salpingography and fallopian tube recanalization art and operative treatment etc. under general hydrotubation, uterine cavity or the peritoneoscope, and all there are distinct disadvantage such as the patient suffering is big, complication is many, expense height in said method.The traditional Chinese medical science think the infertile main pathogenesis of obstructive oviduct be become silted up resistance dash appoint, vessels of the uterus, uterus, can not become pregnant by consolidating semen, face disease and adopt principles treatments such as activating blood circulation to dissipate blood stasis, resolving mass and removing the obstruction of the collateral more.Treatment by Chinese herbs primary disease determined curative effect, but that Chinese medicine for oral administration boils process is loaded down with trivial details, mouthfeel is poor, and certain inconvenience is arranged, and the patient is difficult to adhere to.
Summary of the invention
The purpose of this invention is to provide a kind of fumigating medicine to cauterize navel Chinese medicine composition of treating oviduct obstructive sterility, this medicine is medicine for external use, and is easy and simple to handle, determined curative effect and safety and comfort.
The present invention realizes through following measure:
A kind of fumigating medicine to cauterize navel Chinese medicine composition of treating oviduct obstructive sterility is characterized in that comprising following raw material: Herba speranskiae tuberculatae 10-15g, Sanguis Draxonis 10-20g; Camphora 10-15g, Radix Angelicae Dahuricae 10-15g, Myrrha 10-20g; Olibanum 15-25g, Fructus Evodiae 10-15g, Rhizoma Pinelliae 10-15g; Spina Gleditsiae 10-20g, Borneolum Syntheticum 4-8g.
Preferred said medicine prescription comprises following raw material: Herba speranskiae tuberculatae 12g, Sanguis Draxonis 15g, Camphora 12g, Radix Angelicae Dahuricae 12g, Myrrha 15g, Olibanum 20g, Fructus Evodiae 12g, Rhizoma Pinelliae 12g, Spina Gleditsiae 15g, Borneolum Syntheticum 6g.
Inventor's process years of researches, to the pathogenic characteristic of oviduct obstructive sterility, and the principle of medication that combines umbilicus to treat, through secular clinical practice, finally having obtained prescription of the present invention, the effect of each medicine material is following in the prescription:
Herba speranskiae tuberculatae: hot, bitter, temperature, slightly poisonous, return liver, kidney channel.Expelling wind and removing dampness, detoxifcation pain relieving, but dissipating blood stasis for subsidence of swelling.
Sanguis Draxonis: sweet, salty, flat, GUIXIN, Liver Channel.Removing blood stasis and relieving pain, hemostasia and promoting granulation, be used to fall pounce on lose, ecchymoma due to internal injury, continuous bleeding due to traumatic injury.
Camphora: hot, warm, sensible ward off dirty, warming middle-JIAO to relieve pain, dampness removing parasite killing.Be used for cold-damp and vomit and diarrhoea, stomach abdomen pain, external is controlled scabies, tinea, dental caries and is had a pain.
The Radix Angelicae Dahuricae: suffering, temperature is returned stomach, large intestine, lung meridian.Loose wind dehumidifying, understand things pain-stopping, detumescence and apocenosis are used for headache due to common cold, supraorbital bone pain, nasal obstruction, nasal sinusitis, toothache, leucorrhea, skin infection and swell and ache.
Olibanum, Myrrha: blood circulation promoting and blood stasis dispelling, Chang Xiangxu is a usefulness, says like Compendium of Material Medica: " Olibanum is invigorated blood circulation, and the Myrrha blood that looses all can the alleviating pain and detumescence granulation promoting, so two medicines are often held concurrently mutually and used.”
Fructus Evodiae: hot, bitter, heat, slightly poisonous, return liver, spleen, stomach, kidney channel.Dispersing cold for relieving pain, stopping nausea and vomiting by lowering the adverse flow of QI, supporing yang antidiarrheal.Be used for headache due to JUE YIN disorder, colic of cold type stomachache, the disturbance of lower legs due to pathogenic cold and dampness, abdominal pain during menstruation, abdominal distention, vomiting acid regurgitation, have loose bowels just before dawn.
The Rhizoma Pinelliae: hot, temperature, poisonous, return spleen, stomach, lung meridian.Drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass.Be used for the abundant expectoration cough with asthma, the phlegm retention vertigo and palpitation, dizziness due to wind-phlegm, the syncope due to accumulation of phlegm headache, vomiting regurgitation, breast gastral cavity painful abdominal mass is vexed, and globus hystericus is given birth to external treatment carbuncle sucutaneous nodule.
Spina Gleditsiae: another name Spina Gleditsiae, Fructus Gleditsia acupuncture (Holy Benevolent Prescriptions), day fourth (" detailed outline "), SPINA GLEDITSIAE (" medicine will is planted in Jiangsu "), soap pin (" the Chinese crude drug handbook), hot, warm, return liver, stomach warp.The detumescence poison holding, evacuation of pus, parasite killing.Be used for carbuncle from the beginning of or difficulty in discharging of pus, external treatment scabies leprosy.
Borneolum Syntheticum: hot, bitter, be slightly cold GUIXIN, spleen, lung meridian.Have one's ideas straightened out, pain relieving, " Newly Revised Canon of Materia Medica " said: " main trusted subordinate's pathogen, rheumatism is gathered ", Compendium of Material Medica meaning: " logical all keys ", in this prescription mainly with its network that stimulates the menstrual flow away, take the effect of the through sick institute of all medicines, the osmotic absorption of increase medicine.
Process for preparing medicine of the present invention is simple, with each medicine material mix homogeneously, adopts superfine communication technique to be ground into fine powder, and sealing gets final product.
Medicine of the present invention is a medicine for external use, adopts the fumigating medicine to cauterize navel method in use, and step is:
1. the making of face circle: it is an amount of to get flour, is in harmonious proportion with the ratio water of 1:3.5~4.0, makes circle shape (the about 8cm of diameter, the about 2cm of height), the interstitial hole of face circle should be than the size of patient's umbilical opening big slightly 0.5cm (the about 2.0cm of diameter), subsequent use;
2. the making of moxa cone: carry out making by hand of moxa cone: earlier Folium Artemisiae Argyi is twisted into the Chinese mugwort group that size is fit to according to the new century whole nation high Chinese medicine universities and colleges' planning teaching materials " subject of acupuncture and moxibustion technique "; Be clipped between left hand thumb, the forefinger abdomen; Forefinger will be last, and thumb is wanted infra, and reuse right hand thumb, forefinger inwardly push the group of Chinese mugwort left; Can circle Chinese mugwort group be compressed into point flat prismatic moxa cone down, with making with of.The about 2cm of moxa cone diameter that makes, high about 2cm was advisable to burn in 10~15 minutes;
3. make patient's dorsal position, fully expose umbilical part, with 75% ethanol behind the local routine disinfection of umbilicus; With the face circle around one week of umbilicus, get above-mentioned medicamental pulverata an amount of (about 8~10g), fill up umbilical opening; (the about 2cm of diameter, high about 2cm) places on the medicamental pulverata with moxa cone, and moxibustion 6~9 is strong continuously; About 2h is with the ruddy degree of being of umbilicus week local skin;
4. seal the Qizhong medicamental pulverata admittedly with medical proof fabric after the moxibustion, take off voluntarily after 24 hours, and clean umbilical part with eliminating cold for resuscitation water.Treatment in per 3 days 1 time, continuous 10 times is a course of treatment, suspends during menstrual onset.
This set of guidelines is main to the main pathogenic characteristic of oviduct obstructive sterility with blood circulation promoting and blood stasis dispelling, cooperates simultaneously and is good at walking to scurry the meridians medicine, makes medicine be easier to Transdermal absorption.This medicine is a medicine for external use, has avoided the damage of oral drugs to gastrointestinal, Liver and kidney, has no side effect; And adopt the fumigating medicine to cauterize navel method to treat, have letter, just, test, honest and clean, prompt advantage, existing moxa-moxibustion stimulating acupoint and the effect that produces; Direct effect after the drug absorption is also arranged, and both combine, inner disease outer treat; Treatment oviduct obstructive sterility instant effect, determined curative effect.In addition, medicine of the present invention is cheap and easy to get, and cost is low, and is easy to utilize.
The specific embodiment
Through specific embodiment the present invention is further set forth below, should be understood that, following explanation only is in order to explain the present invention, its content not to be limited.Used each material medicine of the present invention all can have been bought on market.
Embodiment 1
Get Herba speranskiae tuberculatae 12g, Sanguis Draxonis 15g, Camphora 12g, Radix Angelicae Dahuricae 12g, Myrrha 15g, Olibanum 20g, Fructus Evodiae 12g, Rhizoma Pinelliae 12g, Spina Gleditsiae 15g, Borneolum Syntheticum 6g, mix homogeneously adopts superfine communication technique to be ground into fine powder, seals subsequent usely, promptly gets medicine of the present invention.
Embodiment 2
Get Herba speranskiae tuberculatae 10g, Sanguis Draxonis 20g, Camphora 15g, Radix Angelicae Dahuricae 10g, Myrrha 20g, Olibanum 15g, Fructus Evodiae 10g, Rhizoma Pinelliae 10g, Spina Gleditsiae 20g, Borneolum Syntheticum 5g, mix homogeneously adopts superfine communication technique to be ground into fine powder, seals subsequent usely, promptly gets medicine of the present invention.
Embodiment 3
Get Herba speranskiae tuberculatae 15g, Sanguis Draxonis 10g, Camphora 10g, Radix Angelicae Dahuricae 15g, Myrrha 10g, Olibanum 25g, Fructus Evodiae 15g, Rhizoma Pinelliae 15g, Spina Gleditsiae 10g, Borneolum Syntheticum 5g, mix homogeneously adopts superfine communication technique to be ground into fine powder, seals subsequent usely, promptly gets medicine of the present invention.
The infertility that medicine of the present invention causes obstruction of fallopian tube has good therapeutical effect, in order to prove the curative effect of medicine of the present invention, enumerates the part clinical trial at present.
Clinical trial
1, case source
Collect 150 routine infertility patients from certain hospital of this province, its diagnostic result is the obstructed infertility patient who causes of fallopian tube bilateral, and the age, between year, the mean age was 31.5 years old at 25-45.Above-mentioned patient is divided into three groups at random, every group 50 people, not statistically significants such as age, the course of disease between each group.
2, Therapeutic Method
Above-mentioned three groups of patients adopt the embodiment of the invention 1,2,3 made medicines to treat respectively, and Therapeutic Method is above-mentioned disclosed fumigating medicine to cauterize navel method, treatment in per 3 days 1 time, and continuous 10 times is a course of treatment, suspends during menstrual onset, treats 3 courses of treatment continuously.
3, curative effect determinate standard
Recovery from illness: through the uterus, Salpingography inspection or hysteroscope hydrotubation confirm the unobstructed or gestation of bilateral fallopian tube;
Take a turn for the better: radiography or hysteroscope hydrotubation are seen one-sided unobstructed, or radiography shows that the area that blocks focus obviously dwindles;
Invalid: the salpingemphraxis position does not have any change.
Cure rate=cure routine number/total routine number * 100%;
Pregnancy rate=pregnant routine number/total routine number * l00%;
Effective percentage=(the routine number of fully recovering+routine number takes a turn for the better)/total routine number * 100%.
4, therapeutic outcome
The Drug therapy that adopts embodiment 1 is after 3 courses of treatment, 38 examples of fully recovering, and 12 examples that take a turn for the better, invalid 0 example, pregnant 28 examples, cure rate is 76%, pregnancy rate is 56%, effective percentage 100%.
The Drug therapy that adopts embodiment 2 is after 3 courses of treatment, 30 examples of fully recovering, and 15 examples that take a turn for the better, invalid 5 examples, pregnant 22 examples, cure rate is 60%, pregnancy rate is 44%, effective percentage 90%.
The Drug therapy that adopts embodiment 3 is after 3 courses of treatment, 32 examples of fully recovering, and 15 examples that take a turn for the better, invalid 3 examples, pregnant 26 examples, cure rate is 64%, pregnancy rate is 52%, effective percentage 94%.
Can find out that from above-mentioned clinical data medicine of the present invention has good therapeutic effect to oviduct obstructive sterility, see that the effect of drugs of embodiment 1 prescription is best from general curative effect.

Claims (2)

1. a fumigating medicine to cauterize navel Chinese medicine composition of treating oviduct obstructive sterility is characterized in that comprising following raw material: Herba speranskiae tuberculatae 10-15g, Sanguis Draxonis 10-20g; Camphora 10-15g, Radix Angelicae Dahuricae 10-15g, Myrrha 10-20g; Olibanum 15-25g, Fructus Evodiae 10-15g, Rhizoma Pinelliae 10-15g; Spina Gleditsiae 10-20g, Borneolum Syntheticum 4-8g.
2. Chinese medicine composition according to claim 1 is characterized in that comprising following raw material: Herba speranskiae tuberculatae 12g, Sanguis Draxonis 15g, Camphora 12g, Radix Angelicae Dahuricae 12g, Myrrha 15g, Olibanum 20g, Fructus Evodiae 12g, Rhizoma Pinelliae 12g, Spina Gleditsiae 15g, Borneolum Syntheticum 6g.
CN 201110270890 2011-09-14 2011-09-14 Medicine-partition moxibustion navel Chinese medicinal composition for treating tubal obstruction infertility Expired - Fee Related CN102302631B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110270890 CN102302631B (en) 2011-09-14 2011-09-14 Medicine-partition moxibustion navel Chinese medicinal composition for treating tubal obstruction infertility

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110270890 CN102302631B (en) 2011-09-14 2011-09-14 Medicine-partition moxibustion navel Chinese medicinal composition for treating tubal obstruction infertility

Publications (2)

Publication Number Publication Date
CN102302631A true CN102302631A (en) 2012-01-04
CN102302631B CN102302631B (en) 2012-10-31

Family

ID=45376614

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110270890 Expired - Fee Related CN102302631B (en) 2011-09-14 2011-09-14 Medicine-partition moxibustion navel Chinese medicinal composition for treating tubal obstruction infertility

Country Status (1)

Country Link
CN (1) CN102302631B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102600333A (en) * 2012-03-28 2012-07-25 山东中医药大学 Chinese medicinal composition for treating ovulatory dysfunction infertility by umbilical moxibustion
CN103816380A (en) * 2014-03-24 2014-05-28 姜丽莎 Traditional Chinese medicinal composition for treating female infertility

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101077403A (en) * 2007-05-05 2007-11-28 赵启坤 Plaster for treating retention of food and dysmenorrhea

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101077403A (en) * 2007-05-05 2007-11-28 赵启坤 Plaster for treating retention of food and dysmenorrhea

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《山东中医药大学学报》 20060930 郭闫萍 隔药灸脐法治疗排卵障碍性不孕症的临床研究 374-376 1-2 第30卷, 第5期 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102600333A (en) * 2012-03-28 2012-07-25 山东中医药大学 Chinese medicinal composition for treating ovulatory dysfunction infertility by umbilical moxibustion
CN102600333B (en) * 2012-03-28 2013-11-13 山东中医药大学 Chinese medicinal composition for treating ovulatory dysfunction infertility by umbilical moxibustion
CN103816380A (en) * 2014-03-24 2014-05-28 姜丽莎 Traditional Chinese medicinal composition for treating female infertility

Also Published As

Publication number Publication date
CN102302631B (en) 2012-10-31

Similar Documents

Publication Publication Date Title
CN102755537B (en) External Chinese patent medicine for treating lumbocrural pains and application of external Chinese patent medicine
CN103656027A (en) External-application plaster for treating hyperosteogeny
CN103599494A (en) Externally applied traditional Chinese medicine for treatment of cervical spondylosis
CN104189871A (en) Medicated wine for treating osteoproliferation
CN102579711A (en) Medicine-separated navel moxibustion Chinese medicinal composition for treating male erectile dysfunction
CN102228588B (en) Traditional Chinese medicine composition for external use for treating sciatica, and preparation method thereof
CN102008610B (en) Traditional Chinese medicine composition for curing hyperosteogeny
CN102198260B (en) Medicine-partitioned navel moxibustion Chinese medicinal composition for treating dysmenorrhea
CN103495126B (en) Traditional Chinese medicine composition treating rheumatism
CN1895434B (en) Medicine for treating hysteromyoma
CN104922633A (en) Traditional Chinese medicine composition for treating arthralgia as well as preparation method and application method thereof
CN102961483B (en) Traditional Chinese medicine composition for treating pain in waist and lower extremities and preparation method thereof
CN102302631B (en) Medicine-partition moxibustion navel Chinese medicinal composition for treating tubal obstruction infertility
CN102342983B (en) Chinese medicinal composition for treating pain in the legs and numbness of the extremities and preparation method of preparation thereof
CN112022916A (en) Traditional Chinese medicine composition and preparation for treating postpartum body pain and preparation method and application thereof
CN103599472A (en) Traditional Chinese medicinal composition for treating prostatoplasia
CN102772600A (en) Externally used medicine for treating osseous rheumatism
CN102552804A (en) Chinese medicine composite for curing verruca plantaris
CN104587206A (en) Medicament for treating bedsore and preparation method of medicament
CN101721670A (en) External plaster for curing cough, traumatic injury, gynecological inflammation and diarrhea
CN105362987A (en) Traditional Chinese medicine preparation for postpartum care
CN104258285A (en) Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof
CN103768572A (en) Traditional Chinese medicine composition and application thereof
CN101869622A (en) External patch for treating female pelvic inflammation and preparation method thereof
CN102302594B (en) Drug-separated navel moxibustion traditional Chinese drug composition for treating hysteromyoma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20121031

Termination date: 20150914

EXPY Termination of patent right or utility model